Cure My Disease

Don't miss your cure!

 Log in / Sign up

Proton beam therapy aims to prevent lung cancer return after surgery

NCT ID NCT06008730

Recruiting now Disease control Sponsor: Emory University Source: ClinicalTrials.gov ↗

First seen Nov 11, 2025 · Last updated May 13, 2026 · Updated 26 times

Summary

This study tests proton beam radiation in 20 adults with non-small cell lung cancer that has spread to chest lymph nodes and has been surgically removed. The goal is to see if this precise radiation kills leftover cancer cells while sparing healthy tissue, reducing the chance of cancer coming back. Participants will receive proton therapy after surgery and be monitored for side effects and cancer recurrence for up to 2 years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESECTABLE LUNG NON-SMALL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Emory University Hospital/Winship Cancer Institute

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

RESECTABLE LUNG NON-SMALL CELL CARCINOMA